These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 38028782)

  • 1. Potential oxidative stress related targets of mitochondria-focused therapy of PTSD.
    Kmita H; Pinna G; Lushchak VI
    Front Physiol; 2023; 14():1266575. PubMed ID: 38028782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Posttraumatic stress disorder (PTSD) as a consequence of the interaction between an individual genetic susceptibility, a traumatogenic event and a social context].
    Auxéméry Y
    Encephale; 2012 Oct; 38(5):373-80. PubMed ID: 23062450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Anti-Inflammatory Effects of Blueberries in an Animal Model of Post-Traumatic Stress Disorder (PTSD).
    Ebenezer PJ; Wilson CB; Wilson LD; Nair AR; J F
    PLoS One; 2016; 11(9):e0160923. PubMed ID: 27603014
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of suboptimal mitochondrial function in vulnerability to post-traumatic stress disorder.
    Preston G; Kirdar F; Kozicz T
    J Inherit Metab Dis; 2018 Jul; 41(4):585-596. PubMed ID: 29594645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychological therapies for post-traumatic stress disorder and comorbid substance use disorder.
    Roberts NP; Roberts PA; Jones N; Bisson JI
    Cochrane Database Syst Rev; 2016 Apr; 4(4):CD010204. PubMed ID: 27040448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological strategies for post-traumatic stress disorder (PTSD): From animal to clinical studies.
    Gasparyan A; Navarro D; Navarrete F; Manzanares J
    Neuropharmacology; 2022 Nov; 218():109211. PubMed ID: 35973598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mitochondrial dysfunction as a possible trigger of neuroinflammation at post-traumatic stress disorder (PTSD).
    Dmytriv TR; Tsiumpala SA; Semchyshyn HM; Storey KB; Lushchak VI
    Front Physiol; 2023; 14():1222826. PubMed ID: 37942228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased suicidal ideation in depressed patients with or without comorbid posttraumatic stress disorder treated with selective serotonin reuptake inhibitors: an open study.
    Sher L; Stanley BH; Posner K; Arendt M; Grunebaum MF; Neria Y; Mann JJ; Oquendo MA
    Psychiatry Res; 2012 Apr; 196(2-3):261-6. PubMed ID: 22397913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Three paradigms in the treatment of posttraumatic stress disorder].
    Martényi F
    Neuropsychopharmacol Hung; 2005 Mar; 7(1):11-21. PubMed ID: 16167463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Co-Occurrence of Post-Traumatic Stress Disorder and Depression in Individuals with and without Traumatic Brain Injury: A Comprehensive Investigation.
    Simonovic M; Nedovic B; Radisavljevic M; Stojanovic N
    Medicina (Kaunas); 2023 Aug; 59(8):. PubMed ID: 37629756
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SSRIs versus non-SSRIs in post-traumatic stress disorder: an update with recommendations.
    Asnis GM; Kohn SR; Henderson M; Brown NL
    Drugs; 2004; 64(4):383-404. PubMed ID: 14969574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suicidality in patients with post-traumatic stress disorder and its association with receipt of specific secondary mental healthcare treatments.
    Opie E; Werbeloff N; Hayes J; Osborn D; Pitman A
    Int J Psychiatry Clin Pract; 2023 Jun; 27(2):151-160. PubMed ID: 36369845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective serotonin reuptake inhibitors in post-traumatic stress disorder.
    Hidalgo RB; Davidson JR
    J Psychopharmacol; 2000 Mar; 14(1):70-6. PubMed ID: 10757257
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for posttraumatic stress disorder: review with clinical applications.
    Jeffreys M; Capehart B; Friedman MJ
    J Rehabil Res Dev; 2012; 49(5):703-15. PubMed ID: 23015581
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in comorbid depression following intensive trauma-focused treatment for PTSD and complex PTSD.
    Paridaen P; Voorendonk EM; Gomon G; Hoogendoorn EA; van Minnen A; de Jongh A
    Eur J Psychotraumatol; 2023; 14(2):2258313. PubMed ID: 37796651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats.
    Dutta AK; Santra S; Harutyunyan A; Das B; Lisieski MJ; Xu L; Antonio T; Reith MEA; Perrine SA
    Eur J Pharmacol; 2019 Nov; 862():172632. PubMed ID: 31473161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychological treatment of PTSD with comorbid substance use disorder (SUD): expert recommendations of the European Society for Traumatic Stress Studies (ESTSS).
    Roberts NP; Lotzin A; Schäfer I
    Eur J Psychotraumatol; 2023; 14(2):2265773. PubMed ID: 37830207
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelet serotonergic markers in posttraumatic stress disorder.
    Pivac N; Mück-Seler D; Sagud M; Jakovljević M
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1193-8. PubMed ID: 12452545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of trauma and post-traumatic stress disorder on the treatment response of patients with obsessive-compulsive disorder.
    Shavitt RG; Valério C; Fossaluza V; da Silva EM; Cordeiro Q; Diniz JB; Belotto-Silva C; Cordioli AV; Mari J; Miguel EC
    Eur Arch Psychiatry Clin Neurosci; 2010 Mar; 260(2):91-9. PubMed ID: 20077119
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.